Partnerships

Clean Energy Transition

Clean Energy Transition

Partnership website: https://cetpartnership.eu/

The CET Partnership aims to empower the clean energy transition and contribute to the EU’s goal of becoming the first climate-neutral continent by 2050, by pooling national and regional RDTI funding for a broad variety of technologies and system solutions required to make the transition.

The CETPartnership is an co-funded partnership, bringing together private and public stakeholders in the research and innovation ecosystems. CET Partnership aims to create and foster transnational innovation ecosystems and overcome a fragmented research and innovation landscape.

The common vision of the CETPartnership is already manifested in its Strategic Research and Innovation Agenda (SRIA) that has been co-created in a broad engagement process during 2020. This articulates the common goal of:

  • Building innovation ecosystems that support capacity building at all levels
  • Developing and demonstrating technology and solutions for the transition of energy systems
  • Building a transnational transformative Joint Programming Platform

These goals are set in the framework of the EU Strategic Energy Technology (SET) plan. The Call 2023 is structured in 12 Call Modules, corresponding to the 10 challenges as described in the SRIA. A proposal may only apply for one call module. The objectives, scope and impact of each Call Module are defined by the Transition Initiatives' experts. 

A co-funded partnership: participation in Flanders

Flanders Innovation & Entrepreneurship (VLAIO) is an active member in this co-funded partnership. The funding commitment by VLAIO (excluding the top-up by the European Commission) amounts to €1.000.000. A maximum of three projects is anticipated to be funded. The involvement of at least one private company (SME or large enterprise) based in Flanders is mandatory. A project can be awarded a maximum of €500.000 in funding.

Funding rates vary, from 35-60% for development projects to 60-70% for research projects.

Parties interested to participate in the CET Partnership calls in Flanders are highly recommended to get in touch with the VLAIO contact point, i.e. Frank Verschraegen, to avoid ineligible projects and consortia.

Key documents

Contact

What are partnerships?

Partnerships group the EC and private and/or public partners, to coordinate and streamline the research & innovation initiatives and funding in some selected key domains.

More detailed info Overview of partnerships

How to use partnerships?

  • orientation
    Partnerships publish strategic documents, e.g. outlining the main research and innovation challenges or key focus points.
  • networking
    Partnerships often organise events, such as info days, brokerage events, etc. Meet potential partners and learn about the nuances that are not visible in the official documents.
  • ecosystem analysis
    Partnerships typically have an advisory board, and publish impact studies of previous actions. These are good sources of information to uncover the main R&D&I players in the domain.
  • steering the agenda
    Partnerships collaborate with the EC on outlining the strategy and the future funding opportunities in their domain, based on input from industry, academia, and other stakeholders.

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.

Read the full article Check out the other testimonials 
Logo of FWO
Logo of VLAIO

NCP Flanders

Updates

Our Services

Legal mentions

Privacy Policy
Cookies

LinkedIn